EMA Authorised: Silodosin Recordati (silodosin) — Recordati Ireland Ltd

View source ↗

Summary

The EMA authorised Silodosin Recordati for the treatment of benign prostatic hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Silodosin Recordati (silodosin)

Snippet

Status: Authorised. Therapeutic area: Prostatic Hyperplasia. MAH: Recordati Ireland Ltd. Decision date: 10/03/2025